Cargando…
Alzheimer’s disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR‐edited human neuronal cells
Alzheimer's disease (AD) is a pervasive neurodegeneration disease with high heritability. In this study, we employed CRISPR‐Cas9‐engineered technology to investigate the effects of a rare mutation (rs144662445) in the A kinase anchoring protein 9 (AKAP9) gene, which is associated with AD in Afr...
Autores principales: | You, Yang, Hersh, Samuel W., Aslebagh, Roshanak, Shaffer, Scott A., Ikezu, Seiko, Mez, Jesse, Lunetta, Kathryn L., Logue, Mark W., Farrer, Lindsay A., Ikezu, Tsuneya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197405/ https://www.ncbi.nlm.nih.gov/pubmed/35567427 http://dx.doi.org/10.1111/acel.13617 |
Ejemplares similares
-
Tau-tubulin kinase
por: Ikezu, Seiko, et al.
Publicado: (2014) -
Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans
por: Ikezu, Tsuneya, et al.
Publicado: (2018) -
Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice
por: Yukawa, Kayo, et al.
Publicado: (2023) -
Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models
por: Ikezu, Seiko, et al.
Publicado: (2020) -
P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
por: Ruan, Zhi, et al.
Publicado: (2020)